Abstract
Keywords
ADR Reporting (64)Amantadine (81)Apalutamide (70)Atorvastatin (84)Capecitabine (77)Ceftriaxone (68)Chemotherapy (83)Denosumab (65)Dietary Supplements (78,87)Drug-Drug Interactions (69)Dupilumab,Tralokinumab (66)Eye Products (88)Fluoroquinolones (71)Insulin (79)Lenalidomide (72)Levetiracetam,Trimethoprim-Sulfamethoxazole (74)Magnesium (86)Memantine (76)Methadone (85)Nivolumab (80)Opioids (63)Ornidazole (75)Proton Pump Inhibitors (67,73)Psychiatric Medications (90)Rituximab (89)Selective Serotonin Reuptake Inhibitors (91)Sintilimab (82)
Get full access to this article
View all access options for this article.